Xiaomi-W (01810) spent 71.4036 million Hong Kong dollars to repurchase 2.2 million shares on March 27th.

18:38 27/03/2026

Xiaomi Group-W (01810) announced that the company repurchased 2.2 million shares at a total cost of 71.4036 million Hong Kong dollars on March 27, 2026, at a repurchase price of 32.36-32.5 Hong Kong dollars per share.

XIAOMI-W (01810) announced that the company repurchased 2.2 million shares for a total of HK$71.40 million on March 27, 2026, at a repurchase price of HK$32.36-32.5 per share.

LANDSEA LIFE (01965) released its annual performance with a net profit attributable to shareholders of 23.01 million yuan, turning from a loss to a profit year-on-year.

INFINITIES TECH (01961) may delay the publication of its 2025 annual performance. Suspension of trading is expected to begin on April 1st.

Hansoh Pharma (03692): XynQ (Ina-Rilizumab Injection) obtained the National Medical Products Administration certificate for the third indication.

LANDSEA LIFE (01965) released its annual performance with a net profit attributable to shareholders of 23.01 million yuan, turning from a loss to a profit year-on-year.

INFINITIES TECH (01961) may delay the publication of its 2025 annual performance. Suspension of trading is expected to begin on April 1st.

Hansoh Pharma (03692): XynQ (Ina-Rilizumab Injection) obtained the National Medical Products Administration certificate for the third indication.